Chengxun Li

6PUBLICATIONS
11CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 08, 2026
VK-2019 enhances gemcitabine's antitumor activity in EBV-positive nasopharyngeal carcinoma by upregulating PRODH expression.

|Nov 26, 2025
Genomic landscape and molecular subtypes of primary central nervous system lymphoma.

Shengjie Li, Danhui Li, Zuguang Xia

|Sep 30, 2025
Antibody-DNA nanostructure conjugates integrate doxorubicin and rituximab to enhance therapeutic efficacy for DLBCL.

Zuguang Xia, Jiazhen Cao, Yingzhu Li

|Mar 19, 2025
Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma.

Shengjie Li, Jun Ren, Jianing Wu

|Feb 20, 2024
Cholesterol-Modified DNA Nanostructures Serve as Effective Non-Viral Carriers for Delivering siRNA to the Kidneys to Prevent Acute Kidney Injury.

Chengxun Li, Wenzhuo Zhao, Zuojian Hu

|Jan 09, 2023
Nifuroxazide Activates the Parthanatos to Overcome TMPRSS2:ERG Fusion-Positive Prostate Cancer.

Chengxun Li, Jiale Zhang, Qiming Wu

Pageof 1

Frequent Collaborators

3 joint publications

Shengjie Li

2 joint publications

Wenjun Cao

1 joint publications

Jiale Zhang

1 joint publications

Qiming Wu